ImmunityBio (IBRX) Insider Trading & Ownership $4.88 -0.47 (-8.79%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ImmunityBio (NASDAQ:IBRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage83.40%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$268,516.25Number OfInsiders Selling(Last 3 Years)0 Get IBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunityBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IBRX Insider Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. ImmunityBio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/5/2023Michael D BlaszykDirectorBuy71,915$2.75$197,766.25 6/2/2023John Owen BrennanDirectorBuy25,000$2.83$70,750.00 (Data available from 1/1/2013 forward) IBRX Insider Trading Activity - Frequently Asked Questions Who is on ImmunityBio's Insider Roster? The list of insiders at ImmunityBio includes John Owen Brennan, and Michael D Blaszyk. Learn more on insiders at IBRX. What percentage of ImmunityBio stock is owned by insiders? 83.40% of ImmunityBio stock is owned by insiders. Learn more on IBRX's insider holdings. Which ImmunityBio insiders have been buying company stock? The following insiders have purchased IBRX shares in the last 24 months: John Owen Brennan ($70,750.00), and Michael D Blaszyk ($197,766.25). How much insider buying is happening at ImmunityBio? Insiders have purchased a total of 96,915 IBRX shares in the last 24 months for a total of $268,516.25 bought. ImmunityBio Key ExecutivesDr. Patrick Soon-Shiong F.A.C.S. (Age 71)FRCS (C), M.Sc., Executive Chairman of the Board and Global Chief Scientific & Medical Officer Compensation: $865.34kMr. Richard Gerald Adcock (Age 55)President, CEO & Director Compensation: $1.16MMr. David C. Sachs (Age 46)Chief Financial Officer Compensation: $824.62kDr. Barry J. Simon M.D. (Age 59)Chief Corporate Affairs Officer & Director Dr. Leonard S. Sender M.D.Chief Operating OfficerMs. Regan J. Lauer (Age 54)Chief Accounting Officer Dr. Enrique Diloné Ph.D. (Age 57)RAC, Chief Technology Officer Mr. Jason R. Liljestrom (Age 41)General Counsel & Corporate Secretary Ms. Sarah SingletonChief Communications Officer & Head of Patient AdvocacyDr. Sandeep K. Reddy M.D.Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies VCYT Insider Trades IOVA Insider Trades HRMY Insider Trades BCRX Insider Trades FLGT Insider Trades SANA Insider Trades EBS Insider Trades TSHA Insider Trades ALEC Insider Trades SAGE Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:IBRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunityBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunityBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRX Stock Alerts